Psychotropic Medication Use among Insured Children with Autism Spectrum Disorder
Psychotropic Medication Use among Insured Children with Autism Spectrum Disorder
About this item
Full title
Author / Creator
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
This study examined psychotropic medication use among 7901 children aged 1–17 with autism spectrum disorder (ASD) in five health systems, comparing to matched cohorts with no ASD. Nearly half (48.5 %) of children with ASD received psychotropics in the year observed; the most common classes were stimulants, alpha-agonists, or atomoxetine (30.2 %), a...
Alternative Titles
Full title
Psychotropic Medication Use among Insured Children with Autism Spectrum Disorder
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5328123
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5328123
Other Identifiers
ISSN
0162-3257
E-ISSN
1573-3432
DOI
10.1007/s10803-016-2946-7
